{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:40:35Z","timestamp":1792147235035,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T00:00:00Z","timestamp":1431993600000},"content-version":"vor","delay-in-days":352,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ajpath.2014.02.025","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T04:15:24Z","timestamp":1397362524000},"page":"1853-1859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["RB Tumor Suppressive Function in Response to Xenobiotic Hepatocarcinogens"],"prefix":"10.1016","volume":"184","author":[{"given":"Christopher","family":"Reed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Hutcheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher N.","family":"Mayhew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka K.","family":"Witkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik S.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2014.02.025_bib1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"Farazi","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2014.02.025_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/pmj.76.891.4","article-title":"Hepatocellular carcinoma","volume":"76","author":"Badvie","year":"2000","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ajpath.2014.02.025_bib3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2014.02.025_bib4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev.pathol.4.110807.092202","article-title":"Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer","volume":"4","author":"McGivern","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ajpath.2014.02.025_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/jhep.2003.50058","article-title":"Genetic alterations in hepatocellular adenomas","volume":"37","author":"Bioulac-Sage","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2014.02.025_bib6","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/MCB.00205-13","article-title":"Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis","volume":"33","author":"Tian","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ajpath.2014.02.025_bib7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/labinvest.2013.94","article-title":"Linking metabolism and epigenetic regulation in development of hepatocellular carcinoma","volume":"93","author":"Puszyk","year":"2013","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajpath.2014.02.025_bib8","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1038\/sj.onc.1209547","article-title":"Genetics of hepatocellular tumors","volume":"25","author":"Laurent-Puig","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2014.02.025_bib9","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/modpathol.2008.147","article-title":"Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma","volume":"21","author":"Skawran","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2014.02.025_bib10","first-page":"4177","article-title":"Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma","volume":"54","author":"Zhang","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2014.02.025_bib11","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1038\/onc.2009.303","article-title":"RB has a critical role in mediating the in\u00a0vivo checkpoint response, mitigating secondary DNA damage and suppressing liver tumorigenesis initiated by aflatoxin B1","volume":"28","author":"Reed","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.ajpath.2014.02.025_bib12","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/j.gastro.2007.06.025","article-title":"RB loss abrogates cell cycle control and genome integrity to promote liver tumorigenesis","volume":"133","author":"Mayhew","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2014.02.025_bib13","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1074\/jbc.M109.043380","article-title":"Unique impact of RB loss on hepatic proliferation: tumorigenic stresses uncover distinct pathways of cell cycle control","volume":"285","author":"Reed","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2014.02.025_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/mc.1022","volume":"30","author":"Park","year":"2001","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.ajpath.2014.02.025_bib15","doi-asserted-by":"crossref","first-page":"e19758","DOI":"10.1371\/journal.pone.0019758","article-title":"Functional interactions between retinoblastoma and c-MYC in a mouse model of hepatocellular carcinoma","volume":"6","author":"Saddic","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2014.02.025_bib16","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1053\/j.gastro.2011.06.046","article-title":"RB and p53 cooperate to prevent liver tumorigenesis in response to tissue damage","volume":"141","author":"McClendon","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2014.02.025_bib17","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jhep.2008.01.008","article-title":"Experimental models of hepatocellular carcinoma","volume":"48","author":"Newell","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2014.02.025_bib18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.molonc.2013.01.005","article-title":"Mouse models for liver cancer","volume":"7","author":"Bakiri","year":"2013","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ajpath.2014.02.025_bib19","doi-asserted-by":"crossref","first-page":"G449","DOI":"10.1152\/ajpgi.00199.2012","article-title":"Animal models of chronic liver diseases","volume":"304","author":"Liu","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ajpath.2014.02.025_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/carcin\/6.2.225","article-title":"Promoting effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene in mouse hepatocarcinogenesis","volume":"6","author":"Dragani","year":"1985","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ajpath.2014.02.025_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.tox.2007.09.030","article-title":"PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators","volume":"246","author":"Gonzalez","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.ajpath.2014.02.025_bib22","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1158\/0008-5472.CAN-04-4221","article-title":"Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy","volume":"65","author":"Mayhew","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ajpath.2014.02.025_bib23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1053\/bega.2002.0332","article-title":"Animal models of steatohepatitis","volume":"16","author":"Koteish","year":"2002","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.ajpath.2014.02.025_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.molcel.2011.06.029","article-title":"RB restricts DNA damage-initiated tumorigenesis through an LXCXE-dependent mechanism of transcriptional control","volume":"43","author":"Bourgo","year":"2011","journal-title":"Mol Cell"},{"issue":"Pt 3","key":"10.1016\/j.ajpath.2014.02.025_bib25","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1042\/bj2890807","article-title":"1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, an extremely potent modulator of mouse hepatic cytochrome P-450 gene expression","volume":"289","author":"Smith","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/j.ajpath.2014.02.025_bib26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9440(10)64709-8","article-title":"Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-Bis[2-(3,5-Dichloropyridyloxy)] benzene","volume":"156","author":"Ledda-Columbano","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2014.02.025_bib27","first-page":"897","article-title":"Chromosomal instability and human hepatocarcinogenesis","volume":"18","author":"Nishida","year":"2003","journal-title":"Histol Histopathol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014001795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944014001795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:44:51Z","timestamp":1757601891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944014001795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0002944014001795"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2014.02.025","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RB Tumor Suppressive Function in Response to Xenobiotic Hepatocarcinogens","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2014.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}